Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Priscilla B. Pujatti"'
Autor:
Lídia F Fontes, Priscilla B Pujatti, Jorge W E da Silva, Célia H Costa, Cláudia Palhota, Antônio P de Oliveira, Rossana C R de Mello
Publikováno v:
Radiation Protection Dosimetry.
COVID-2019 has resulted in an emerging respiratory infection that has spread as a pandemic since January 2020. Nuclear Medicine Services and its workers experienced a dramatic change in their clinical routine. They were required to adjust protocols f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a68f067afb23eba215dada3815cddf9d
https://doi.org/10.1093/rpd/ncad163
https://doi.org/10.1093/rpd/ncad163
Autor:
Patrick Jack Spencer, Miriam F. Suzuki, Lais F. Alcarde, Priscilla B. Pujatti, Adriana V.F. Massicano, Elaine Bortoleti de Araújo
Publikováno v:
Current Radiopharmaceuticals. 9:54-63
The optimization of DOTA-NHS-ester conjugation to Rituximab using different Ab:DOTA molar ratios (1:10, 1:20, 1:50 and 1:100) was studied. High radiochemical yield, in vitro stability and immunoreactive fraction were obtained for the Rituximab conjug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::775c0921c6a05dcb708e4d1966725c86
https://doi.org/10.2174/1874471008666150313103849
https://doi.org/10.2174/1874471008666150313103849
Autor:
Julie Foster, Elaine Bortoleti de Araújo, Priscilla B. Pujatti, Kerly F.M. Pasqualoto, Jane K. Sosabowski, Stephen J. Mather, Jerome Burnet, Ciara Finucane, Jair Mengatti, Chantelle D. Hudson
Publikováno v:
Applied Radiation and Isotopes. 96:91-101
We evaluated and compared a new bombesin analog [Tyr–Gly 5 , Nle 14 ]-BBN(6–14) conjugated to DOTA or DTPA and radiolabeled with In-111 in low and high GRPR expressing tumor models. Both peptides were radiolabeled with high radiochemical purity a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a15fbbd38e20fce7f02b88271911efa
https://doi.org/10.1016/j.apradiso.2014.11.006
https://doi.org/10.1016/j.apradiso.2014.11.006
Autor:
Adriana V F, Massicano, Priscilla B, Pujatti, Lais F, Alcarde, Miriam F, Suzuki, Patrick J, Spencer, Elaine B, Araújo
Publikováno v:
Current radiopharmaceuticals. 9(1)
The optimization of DOTA-NHS-ester conjugation to Rituximab using different Ab:DOTA molar ratios (1:10, 1:20, 1:50 and 1:100) was studied. High radiochemical yield, in vitro stability and immunoreactive fraction were obtained for the Rituximab conjug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ba15f44f91330883d9d3fd00d16ab286
https://pubmed.ncbi.nlm.nih.gov/25771373
https://pubmed.ncbi.nlm.nih.gov/25771373
Autor:
Priscilla B. Pujatti, Maria Tereza Colturato, Emiko Muramoto, C.P.G. Silva, R.M. Couto, J.S. Caldeira Filho, E.B. de Araújo, L.T. Nagamati, Jair Mengatti
Publikováno v:
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine. 67(2)
This work analysed the influence of the chelating group and radioligand on somatostatin analogues in vivo and in vitro properties. The presence of DOTA in the radioiodinated peptide produced a labeled analogue with similar blood kinetics and biodistr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d1f4085b6e5932b8e5cb88c21863178
https://pubmed.ncbi.nlm.nih.gov/19027307
https://pubmed.ncbi.nlm.nih.gov/19027307
Publikováno v:
Nuclear Medicine and Biology. 37:693
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::399d59c837414fe860c8c214bfc63c9e
https://doi.org/10.1016/j.nucmedbio.2010.04.091
https://doi.org/10.1016/j.nucmedbio.2010.04.091